Table 1.
Mean zone of inhibition in mm ± Standard deviation beyond well diameter (6 mm) produced on a range of environmental and clinically pathogenic microorganisms using (125 µg/mL) concentration of tested samples.
| Comp. | Invasive Fungi | Dermatophytic Fungi | ||||||
|---|---|---|---|---|---|---|---|---|
| CaR | Ca | Ct | Cp | Af | An | Tm | Mc | |
| 6a | 14.2 ± 0.58 | 12.4 ± 0.63 | 11.5 ± 0.58 | 12.4 ± 0.63 | 11.2 ± 0.63 | 11.9 ± 0.63 | 9.3 ± 0.63 | 10.2 ± 0.63 |
| 8a | 18.2 ± 0.72 | 20.3 ± 0.63 | 19.4 ± 0.58 | 20.6 ± 0.63 | NA | NA | NA | NA |
| 10a | NA | 12.3 ± 0.63 | 14.1 ± 0.63 | 15.2 ± 0.58 | 10.6 ± 0.72 | 9.3 ± 0.58 | 10.1 ± 0.63 | 12.1 ± 0.58 |
| 10b | 19.6 ± 0.63 | 20.9 ± 0.72 | 21.2 ± 0.45 | 22.4 ± 0.58 | NA | NA | NA | NA |
| 10e | NA | NA | NA | NA | 20.3 ± 0.63 | 18.2 ± 0.63 | 17.1 ± 0.63 | 18.9 ± 0.63 |
| 12a | NA | NA | NA | NA | 19.3 ± 0.72 | 18.1 ± 0.58 | 18.2 ± 0.72 | 20.1 ± 0.58 |
| Flu | NA | 16.6 ± 0.58 | 15.4 ± 0.58 | 17.2 ± 0.72 | 19.6 ± 0.58 | 16.3 ± 0.63 | 13.6 ± 0.72 | 15.4 ± 0.63 |
Only the compounds with I.Z > 9 mm are mentioned. NA: No Activity (I.Z < 9 mm). The screening organisms, Invasive Fungi: fluconazole resistant Candida albicans (RCMB 05036, CaR), Candida albicans (RCMB 05079, Ca), Candida tropicalis (RCMB 05142, Ct), Candida parapsilosis (RCMB 05324, Cp); Aspergillus fumigatus (RCMB 02568, Af) and Aspergillus niger (RCMB 02542, An). Dermatophytic Fungi: Trichophytons mentagrophytes (RCMB 09285, Tm) and Microsporum canis (RCMB 09321, Mc); Flu: Fluconazole.